See full prescribing information for yorvipath. Conventional therapy for hypoparathyroidism consists of active vitamin d (e.g., calcitriol or its analog alfacalcidol) and calcium supplementation. Yorvipath is indicated for the treatment of hypoparathyroidism in adults
Forrest (@forresttsmith) – Forrest Smith: The Male Influencer
The fda has approved yorvipath (palopegteriparatide) injection for subcutaneous use in adults with hypoparathyroidism
